During the past decade, Shanghai Dermatology Hospital conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 3 clinical trials were completed, i.e. on average, 21.4% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 3 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Shanghai Dermatology Hospital" #1 sponsor was "Pfizer" with 3 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "Shanghai Dermatology Hospital" with 2 trials sponsored, "Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd." with 2 trials sponsored and "Shanghai Yueyang Integrated Medicine Hospital" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shanghai Dermatology Hospital" #1 collaborator was "Wuhan No.1 Hospital" with 3 trials as a collaborator, "Chinese Medicine Hospital Affiliated to Southwest Medical University" with 2 trials as a collaborator, "Jiangsu Province Hospital of Traditional Chinese Medicine" with 2 trials as a collaborator, "Shanghai Dermatology Hospital" with 2 trials as a collaborator and "The Second People's Hospital Affiliated to Fujian University of TCM" with 2 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "Shanghai Dermatology Hospital" are "Psoriasis" (3 trials), "Actinic Keratoses" (2 trials), "Dermatitis, Atopic" (2 trials), "Eczema" (2 trials) and "Plaque Psoriasis" (2 trials). Many other conditions were trialed in "Shanghai Dermatology Hospital" in a lesser frequency.

Most popular intervention types in "Shanghai Dermatology Hospital" are "Drug" (12 trials), "Device" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "ALA" (1 trials), "ALA 10%" (1 trials), "ALA 2.5%" (1 trials) and "ALA 5%" (1 trials). Other intervention names were less common.

The vast majority of trials in "Shanghai Dermatology Hospital" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Shanghai Dermatology Hospital". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Shanghai Dermatology Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Shanghai Dermatology Hospital, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".